ÌÇÐÄvlog´«Ã½

Global Patient Registry Software Market Size (2024 - 2029)

The global patient registry software market is projected to experience significant growth over the forecast period, driven by various factors such as government initiatives, the increasing adoption of electronic health records, and the expanding use of registry data for post-marketing surveillance. The market's expansion is further supported by the launch of new registries and strategic mergers and acquisitions. However, challenges related to privacy, data security, and a shortage of skilled professionals may hinder the market's growth. Despite these challenges, the market is expected to expand due to the ongoing demand for innovative and cost-effective healthcare solutions.

Market Size of Global Patient Registry Software Industry

Patient Registry Software Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.72 Billion
Market Size (2029) USD 3.12 Billion
CAGR (2024 - 2029) 12.53 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Patient Registry Software Market Major Players

*Disclaimer: Major Players sorted in no particular order

Patient Registry Software Market Analysis

The Global Patient Registry Software Market size is estimated at USD 1.72 billion in 2024, and is expected to reach USD 3.12 billion by 2029, growing at a CAGR of 12.53% during the forecast period (2024-2029).

COVID-19 is expected to have a significant impact on the growth of the market. The patient registry during COVID-19 was used to register the symptoms of COVID-19 in the patients, the impact of vaccination trials, post-marketing authorization of vaccines, and further research and development activities in innovating vaccines. Furthermore, in August 2020, IQVIA launched its COVID Active Research Experience (CARE) Project at helpstopcovid19.com. The IQVIA CARE Project is an opt-in registry available to anyone to advance understanding of COVID-19 through shared information about disease prevalence, symptom progression, and treatment outcomes. Data science innovations supported by patient registries can provide critical missing pieces to support COVID-19 efforts. Thus, COVID-19 is expected to impact the growth of the market during the forecast period.

Certain factors that are driving the market growth include the implementation of government initiatives to build patient registries, the rising adoption of electronic health records (EHR), and the increasing use of patient registry data for post-marketing surveillance.

Owing to the improved outcomes and quality of care in the 21st century, market players around the world are looking for innovative and cost-effective ways to deliver technology-enabled, patient-centered healthcare solutions, both inside and outside hospital walls. Due to widespread applications, including clinical and non-clinical, electronic health records have been able to attract attention from government sources. Many federal policies, actions, and programs are being initiated by the government of developed and developing countries across the world to experience progress in healthcare services.

The launch of new patient registries across the world and the adoption of key strategies, like mergers and acquisitions, are expected to drive market growth during the study period. For instance, in April 2022, Cerner launched a registry that will collect data from patients diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disease. It will collect retrospective and prospective clinical and health outcome data for patients diagnosed with Gaucher disease. It is focused on accelerating the discovery, development, and delivery of insights and therapies to improve health.

In February 2022, Canadian Neuromuscular Disease Registry launched a new registry for patients with congenital myasthenic syndrome (CMS). This registry aims to improve access to diagnosis and treatment and develop a Canadian CMS cohort for future research. Thus, such government initiatives boosting the adoption of patient registries will boost market growth.

Thus, due to the above-mentioned factors, the studied market is expected to augment during the study period. However, concerns relating to privacy and data security are inhibiting the growth of the global patient registry software market. Moreover, the lack of trained and skilled professionals is limiting the market.

Patient Registry Software Industry Segmentation

As per the scope of the report, patient registry software deals with an organized system, which uses observational study methods to collect uniform data (clinical and other) for the evaluation of specified outcomes for a population, defined by a specific disease, condition, or exposure, and which further serves one or more predetermined scientific, clinical, or policy purposes. The Patient Registry Software Market is Segmented By Type of Registry (Disease Registries, Health Service Registries, and Product Registries), Type of Software (Stand-alone Software and Integrated Software), End User (Hospitals, Government Organizations, and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other End Users), and Geography (North America, Europe, Asia - Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Type of Registry
Disease Registries
Health Service Registries
Product Registries
By Type of Software
Stand-alone Software
Integrated Software
By End User
Hospitals
Government Organizations and Third Party Administrators (TPAs)
Pharmaceutical, Biotechnology, and Medical Device Companies
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Patient Registry Software Market Size Summary

The patient registry software market is poised for significant growth, driven by the increasing adoption of electronic health records and government initiatives aimed at building comprehensive patient registries. The market is experiencing a surge in demand due to its critical role in enhancing healthcare outcomes and quality of care. The COVID-19 pandemic has further accelerated this trend, as patient registries were instrumental in tracking disease symptoms, vaccination trials, and post-marketing surveillance. Innovations in data science, supported by these registries, have been pivotal in advancing understanding and treatment of COVID-19. The market is characterized by the launch of new registries and strategic partnerships, such as mergers and acquisitions, which are expected to propel growth during the forecast period.

North America is anticipated to lead the market, with the United States at the forefront due to its early adoption of digital healthcare infrastructure and supportive government policies. The region's growth is bolstered by increased research and development activities by pharmaceutical companies and the rising adoption of patient registry software. The market's competitive landscape is marked by the presence of key players like IQVIA, Dacima Software Inc., and FIGmd Inc., who are actively engaging in product launches and strategic collaborations to expand their offerings. Despite challenges related to privacy concerns and a shortage of skilled professionals, the market is expected to thrive, driven by the integration of patient data and the development of innovative software solutions.

Explore More

Global Patient Registry Software Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Implementation of Government Initiatives to Build Patient Registries

      2. 1.2.2 Rising Adoption of Electronic Health Records (EHR)

      3. 1.2.3 Increasing Use of Patient Registry Data for Post-marketing Surveillance

    3. 1.3 Market Restraints

      1. 1.3.1 Privacy and Data Security-related Concerns

      2. 1.3.2 Lack of Trained and Skilled Resources

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD Million)

    1. 2.1 By Type of Registry

      1. 2.1.1 Disease Registries

      2. 2.1.2 Health Service Registries

      3. 2.1.3 Product Registries

    2. 2.2 By Type of Software

      1. 2.2.1 Stand-alone Software

      2. 2.2.2 Integrated Software

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Government Organizations and Third Party Administrators (TPAs)

      3. 2.3.3 Pharmaceutical, Biotechnology, and Medical Device Companies

      4. 2.3.4 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East & Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East & Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Patient Registry Software Market Size FAQs

The Global Patient Registry Software Market size is expected to reach USD 1.72 billion in 2024 and grow at a CAGR of 12.53% to reach USD 3.12 billion by 2029.

In 2024, the Global Patient Registry Software Market size is expected to reach USD 1.72 billion.

Patient Registry Software Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)